课题基金 / 基金详情

Development of Imaging and Quantitation of Gene Induction and Expression using Nuclear Medicine Technique

Development of Imaging and Quantitation of Gene Induction and Expression using Nuclear Medicine Technique
利用核医学技术开发基因诱导和表达的成像和定量
批准号:
13670917
负责人:
ORIUCHI Noboru
金额:
$1.54万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2001
资助国家:
日本
项目状态:
已结题
起止时间:
2001 至 2002

项目摘要

项目成果

ORIUCHI Noboru的其他基金

相似基金

相关文献

中文摘要
翻译
为了用正电子发射断层扫描评价正电子发射体标记的放射性药物在脑肿瘤中的摄取,对示踪剂摄取进行了体外评价。首先,我们在星形细胞瘤细胞系SW1088和U-118 MG中进行了[F-18]脱氧葡萄糖(FDG)摄取实验。这些细胞系对FDG的摄取以细胞数量依赖的方式增加。当细胞数为15×104和21×104时,这些细胞对FDG的摄取率分别为26.7%和32.5%。其次使用氨基酸示踪剂[F-18]氟甲基酪氨酸(FMT)。当细胞数为7.5×104和10.8×104时,FMT的摄取率分别为7.7%和10.8%。第三,我们使用了[C-11]胆碱:磷脂酰胆碱的前体。U-118 MG在细胞数为17×10~(-4)时的摄取率为11.2%,且摄取具有温度依赖性。结果表明,这些细胞系积累了正电子发射体标记的葡萄糖、氨基酸和胆碱等生物标志物,并可以进行定量评估。虽然FDG是诊断恶性肿瘤的有代表性的示踪剂,但它的摄取并不是恶性肿瘤所特有的。FMT和[C-11]胆碱也可用于细胞增殖和肿瘤恶性程度的诊断。根据这些结果,可以通过摄取FDG作为葡萄糖代谢的示踪剂,以及FAMT和[C-11]胆碱作为示踪剂来评估基因治疗的效果。利用核医学技术可以对基因的诱导和表达进行评估。
英文摘要
To evaluate the uptake of radiopharmaceuticals labeled with positron emitter in the brain tumor using positron emission tomography, in vitro evaluation of tracer uptake was examined. Firstly we performed [F-18] fluorodeoxyglucose (FDG) uptake in astrocytoma cell lines SW1088 and U-118MG. Uptake of FDG in these cell lines increased in a cell number dependent manner. The uptake of FDG in these cell lines was 26.7% and 32.5% at cell number of 15×10^4 and 21×10^4, respectively. Secondly amino-acid tracer [F-18] fluoromethyl tyrosine (FMT) was used. The uptake of FMT was 7.7% and 10.8% at cell number of 7.5×10^4 and 10.8×10^4, respectively. Tertiary we used [C-11] choline : precursor of phosphatidyl choline. The uptake in U-118MG was 11.2% at cell number of 17×10^4 and the uptake was temperature dependent. The results indicated that these cell lines accumulate positron emitter labeled biomarkers of glucose, amino acid and choline, and quantitative evaluation was possible.Clinical evaluation of these tracers was performed in cases with brain tumor. Although FDG is a representative tracer for the diagnosis of malignant tumors, its uptake is not specific for the malignant tumor. FMT and [C-11] choline may be also useful for the diagnosis in terms of cell proliferation and tumor malignancy.Based on these results the effect of gene therapy could be evaluated by the uptake of FDG as a tracer for glucose metabolism and also FAMT and [C-11] choline as tracers to correlate activity of tumor. Gene induction and evaluation of its expression could be evaluable by means of nuclear medicine technique.
期刊论文(23)
专著(0)
科研奖励(0)
会议论文
Masahiko Tosaka: "Cerebrospinal fluid immunocytochemical analysis and neuroimaging in the diagnosis of primary leptomeningeal melanoma"J Neurosurg. 94. 528-532 (2001)
Masahiko Tosaka:“脑脊液免疫细胞化学分析和神经影像学诊断原发性软脑膜黑色素瘤”J Neurosurg。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Kato H.: "Comparison between positron emission tomography and computed tomography in the use of the assessment of esophageal carcinoma"Cancer. 94. 921-928 (2002)
Kato H.:“正电子发射断层扫描和计算机断层扫描在食管癌评估中的应用比较”癌症。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Tomio Inoue: "Detection of malignant tumors : Whole-body PET with fluorine 18 α-methyl tyrosine versus FDG preliminary study"Radiology. 220. 54-62 (2001)
Tomio Inoue:“恶性肿瘤的检测:氟 18 α-甲基酪氨酸与 FDG 的全身 PET 对比初步研究”放射学。 220. 54-62 (2001)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Zhang H: "Oncological diagnosis using positron coincidence gamma camera with fluorodeoxyglucose in comparison with dedicated PET"The British Journal of Radiology. 75. 409-416 (2002)
张浩:“使用正电子符合伽马相机和氟脱氧葡萄糖与专用 PET 进行肿瘤诊断”英国放射学杂志。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
共 21 条
    Application of F-18-FMT PET for amino acid transporter targetedcancer therapy
    • 批准号:
      22300334
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $9.73万
    • 财政年份:
      2010
    • 负责人:
      ORIUCHI Noboru
    • 依托单位:
    Diagnostic performance and prognostic value of ^<18>F-FAMT PET in non-small cell lung cancer
    • 批准号:
      19591400
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.58万
    • 财政年份:
      2007
    • 负责人:
      ORIUCHI Noboru
    • 依托单位:
    Studies on optimal evaluation of the effect and recurrence of molecular-targeting therapy using positron emission tomography
    • 批准号:
      15591255
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $1.6万
    • 财政年份:
      2003
    • 负责人:
      ORIUCHI Noboru
    • 依托单位:
    Selective therapy of malignant lymphoma with novel radiolabeled antibody
    • 批准号:
      10670825
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $1.02万
    • 财政年份:
      1998
    • 负责人:
      ORIUCHI Noboru
    • 依托单位:
    国内基金
    海外基金
    基于薄层增强CT联合18F-FDG PET/CT评估直接手术的非小细胞肺癌患者纵隔淋巴结转移及其预后的研究
    • 批准号:
      2026JJ82072
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      杨晓煌
    • 依托单位:
    肺腺癌糖代谢靶点TPI 1表达的机制及基于18F-FDG PET/CT影像的深度学习预测模型研究
    雌激素受体阳性乳腺癌新辅助治疗早期应答机制与预测模型研究:基于18F-FDG/18F-FES PET/CT的代谢-受体整合分析
    • 批准号:
      2026JJ82385
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      张艳银
    • 依托单位:
    基于多模态18F-FDG及18F-FAPI PET/CT影像特征预测口腔鳞癌新辅助化学免疫治疗应答及构建预后预测模型
    • 批准号:
      JCZRLH202600661
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
    • 依托单位: